Congratulations to faculty in Otolaryngology who learned this week that their NIH grants were funded. Nathan Welham, PhD and Diane Bless, PhD will receive over $3.5M over five years for their R01 renewal, “Characterization and Treatment of the Scarred Vocal Fold.” Sam Gubbels, MD will receive $439,380 over 3 years for his R03, “The Use of Pluripotent Stem Cell Technology for the Study and Treatment of Human Hearing Loss.”
The Executive Committee of the Biological Sciences Division voted unanimously to recommend Dixon Kaufman, MD, PhD for appointment at the rank of Professor with tenure effective February 1, 2012.
The School of Medicine and Public Health CHS Appointments and Promotions Committee unanimously approved Dr. Becky Sippel’s promotion to Associate Professor CHS effective July 1, 2011.
On February 4, a multidisciplinary team showed how preparation, teamwork, and new technology can change the way we care for the sickest patients in Wisconsin. A patient with a traumatic aortic injury experienced in an auto accident was transferred via helicopter to UW where a Thoracic EndoVascular Aortic Repair (TEVAR) was performed. This is the first on-label use of TEVAR performed under local anesthesia in the state of Wisconsin, where vascular surgery leads the nation in training physicians in this new procedure.
Ankush Gosain, MD, PhD was notified that his chapter “Liver & Portal” written for the American College of Surgeons, will be a “featured chapter” at surgical education week. It will be part of the core curriculum for SCORE (Surgical Council on Resident Education), which will be the centerpiece of ACS resident education.
Kudos to Deb Gawin, RN, BSN, CCRC, who coordinates many translational clinical trials in the Department of Surgery. Dr. Cliff Cho emailed about Deb’s great work and when thanked she said “today has been even more crazy than usual. We are attempting to randomize 2 pancreatic cancer vaccine patients, we consented a patient to a liver resection study, and we evaluated a patient for the Kudsk Sepsis study.” The group of Deb, Cass Nunez and Emily Phelps currently manage 18 trials and over 200 IRBs.